33.70

1.63% 0.54

After Hours: 33.70

Edgewise Therapeutics Inc (EWTX)

Overview News Price History Option Chain Financials Discussions Forecast

Edgewise Therapeutics Inc stock is traded at $33.70, with a volume of 1.24M. It is up +1.63% in the last 24 hours and up +13.89% over the past month. Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is developing novel therapeutics for muscular dystrophies and serious cardiac conditions. The company's product candidates are Sevasemten, EDG-7500, EDG-003, and EDG-15400. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies, including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company's products are currently in different stages of their development, being developed to target key muscle proteins and modulators to address a broad array of muscle diseases.

Previous Close:

$33.16

Open:

$33

24h Volume:

1.24M

Relative Volume:

1.33

Market Cap:

$3.62B

Revenue:

Net Income/Loss:

$-167.80M

P/E Ratio:

-20.65

EPS:

-1.6323

Net Cash Flow:

$-144.07M

1W Performance:

+2.00%

1M Performance:

+13.89%

6M Performance:

+115.75%

1Y Performance:

+158.83%

1-Day Range:

$32.57

$33.91

1-Week Range:

$32.26

$34.77

52-Week Range:

$12.15

$34.77

Edgewise Therapeutics Inc Stock (EWTX) Company Profile

Name

Edgewise Therapeutics Inc

Sector

Healthcare (1112)

Industry

Biotechnology (621)

Phone

720-262-7002

Address

1715 38TH ST, BOULDER

Employee

146

Twitter

Next Earnings Date

2025-03-03

Latest SEC Filings

EWTX's Discussions on Twitter

Compare EWTX vs VRTX, REGN, ARGX, ALNY, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
EWTX Edgewise Therapeutics Inc	33.70	3.56B	0	-167.80M	-144.07M	-1.6323
VRTX Vertex Pharmaceuticals Inc	441.70	113.01B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	753.93	79.87B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	840.87	51.51B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	333.39	45.29B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	319.94	34.41B	5.36B	287.73M	924.18M	2.5229

Edgewise Therapeutics Inc Stock (EWTX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-25-25	Initiated	Goldman	Neutral
Jul-30-25	Initiated	Raymond James	Strong Buy
Jun-30-25	Initiated	H.C. Wainwright	Buy
Apr-30-25	Initiated	Guggenheim	Buy
Apr-02-25	Downgrade	Scotiabank	Sector Outperform → Sector Perform
Mar-07-25	Initiated	Scotiabank	Sector Outperform
Jan-22-25	Initiated	Stifel	Hold
Nov-22-24	Initiated	Evercore ISI	Outperform
Mar-07-24	Initiated	Piper Sandler	Overweight
May-01-23	Initiated	Truist	Buy
Aug-25-22	Downgrade	Goldman	Neutral → Sell
Apr-13-22	Initiated	RBC Capital Mkts	Outperform
Jan-28-22	Initiated	Goldman	Neutral

View All

Edgewise Therapeutics Inc Stock (EWTX) Latest News

Apr 13, 2026

Edgewise Therapeutics stock hits 52-week high at 34.03 USD - Investing.com

Apr 13, 2026

Edgewise Therapeutics stock hits 52-week high at 34.03 USD By Investing.com - Investing.com India

Apr 13, 2026

Retail Surge: Can Edgewise Therapeutics Inc expand its profit marginsTrade Performance Summary & Risk Managed Trade Strategies - baoquankhu1.vn

Apr 13, 2026

Analysts Bullish on Edgewise Therapeutics Stock - National Today

Apr 13, 2026

Apr 10, 2026

Bull Run: Will Edgewise Therapeutics Inc stock hit new highs in YEAR2026 Geopolitical Influence & Safe Entry Point Identification - baoquankhu1.vn

Apr 10, 2026

Apr 09, 2026

Behavioral Patterns of EWTX and Institutional Flows - Stock Traders Daily

Apr 09, 2026

Ideas Watch: Will Edgewise Therapeutics Inc stock hit new highs in YEARInsider Selling & Verified Short-Term Trading Plans - baoquankhu1.vn

Apr 09, 2026

Apr 08, 2026

History Review: Will Edgewise Therapeutics Inc stock hit new highs in YEAR2026 Opening Moves & Smart Investment Allocation Tips - baoquankhu1.vn

Apr 08, 2026

Aug Rallies: Can Edgewise Therapeutics Inc grow without dilutionWeekly Loss Report & Community Trade Idea Sharing Platform - baoquankhu1.vn

Apr 08, 2026

Apr 07, 2026

Edgewise Therapeutics (NASDAQ:EWTX) Reaches New 12-Month HighShould You Buy? - MarketBeat

Apr 07, 2026

Aberdeen Group plc Increases Position in Edgewise Therapeutics, Inc. $EWTX - MarketBeat

Apr 07, 2026

Apr 06, 2026

Aug Wrap: Is Edgewise Therapeutics Inc a cyclical or defensive stockMarket Activity Report & Weekly Stock Breakout Alerts - baoquankhu1.vn

Apr 06, 2026

Update Recap: Can Edgewise Therapeutics Inc reach all time highs this year2026 Investor Takeaways & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn

Apr 06, 2026

Why Edgewise Therapeutics (EWTX) Is Up 8.1% After New Sevasemten BMD Data And Analyst Interest - Sahm

Apr 06, 2026

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat

Apr 06, 2026

Apr 05, 2026

Edgewise Therapeutics (EWTX) Valuation After Positive Becker Muscular Dystrophy Extension Data - Sahm

Apr 05, 2026

Breakouts Watch: Is Edgewise Therapeutics Inc subject to activist investor interest2026 Action & Free Technical Pattern Based Buy Signals - baoquankhu1.vn

Apr 05, 2026

SG Americas Securities Boosts Stake in Edgewise Therapeutics - National Today

Apr 05, 2026

SG Americas Securities LLC Buys 78,842 Shares of Edgewise Therapeutics, Inc. $EWTX - MarketBeat

Apr 05, 2026

Breakout Move: Is Edgewise Therapeutics Inc being accumulated by smart moneyMarket Performance Summary & Daily Technical Forecast Reports - baoquankhu1.vn

Apr 05, 2026

Apr 03, 2026

Director at Edgewise Therapeutics (EWTX) awarded 339 new shares - Stock Titan

Apr 03, 2026

Edgewise Therapeutics stock hits 52-week high at 33.5 USD By Investing.com - Investing.com Canada

Apr 03, 2026